What Do We Know About 5-Alpha Reductase Inhibitors?

    January 2018 in “ Surgical and Cosmetic Dermatology
    Juliana de Lira Machado, Miguel Sánchez Viera, Nerea Felip Santamaria
    Image of study
    TLDR 5-alpha reductase inhibitors like finasteride and dutasteride are effective for treating enlarged prostate and male pattern hair loss.
    Five years ago, a comprehensive review was conducted on the efficacy and safety of 5-alpha reductase inhibitors, specifically finasteride and dutasteride. These drugs, which have antiandrogenic properties, are commonly used to treat benign prostatic hyperplasia and androgenic alopecia. The U.S. Food and Drug Administration (FDA) approved finasteride in 1991 for benign prostatic hyperplasia and in 1997 for male androgenetic alopecia. Dutasteride was approved by the FDA in 2002 for benign prostatic hyperplasia and is approved in Japan and South Korea for treating male androgenetic alopecia.
    Discuss this study in the Community →


    12 / 12 results